MedPath

Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain

Not Applicable
Completed
Conditions
Generalized Anxiety Disorder
Registration Number
NCT01128309
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • participation in the study 'Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects" by Dr. Elizabeth Hoge
Exclusion Criteria
  • metallic implants
  • left handed
  • epileptic seizures
  • head trauma
  • weight over 350 pounds
  • claustrophobia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
brain activation and structure as assessed by MRIDay 2 (within two weeks after the intervention)

BOLD functional MRI and structural MRI

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Charlestown, Massachusetts, United States

Massachusetts General Hospital
🇺🇸Charlestown, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.